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1. Introduction  
Liquid chromatography/tandem mass spectrometry (LC-MS/MS) with electrospray 
ionization is a highly specific and sensitive analytical technique that has become the 
industry standard for quantifying drugs, metabolites, and endogenous compounds in 
biological matrices (e.g. plasma). The technique is widely used because of its ability to 
accurately quantitate analytes of interest with minimal sample clean-up and rapid LC 
separation. Despite these advantages, LC-MS/MS methodology occasionally encounters 
problems, some of which are caused by matrix effects. 
The “matrix” refers to all components in the sample other than the analyte(s) of interest. 
Some common matrices typically encountered by bioanalytical scientists include blood, 
plasma, urine, bile, feces, and tissue samples. Although these complex matrices have a 
number of common components, not all are known and levels may vary among individuals. 
For example, plasma samples obtained from different patients enrolled in clinical trial 
studies may contain different levels of endogenous components based on their genetics 
and/or disease state as well as different drugs used to manage their disease. Consequently, 
each patient’s plasma may have its own particular set of matrix components and therefore is 
viewed as being a unique sample. Matrix effects can arise from a number of matrix 
components including, but not limited to: 
 Endogenous biological components such as phospholipids, carbohydrates, and 
endogenous metabolites (bilirubin) 
 Residual formulation components from intraperitoneal (ip), intravenous (iv), or oral 
dosing (po) experiments; for example, polyethylene glycol (PEG), solutol, polysorbate 
(Tween 80), etc. 
 An interaction between the analyte of interest and the matrix, such as covalent binding 
to plasma proteins or the enzymatic degradation of a prodrug 
 Co-eluting drug metabolites 
 Concomitant medications 
 Mobile phase additives 
A matrix effect is generally encountered when a component, for example a phospholipid 
(present in plasma) co-elutes with the analyte of interest and causes a decrease (suppression) 
or increase (enhancement) in ionization efficiency relative to the analyte eluting in the 
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absence of the matrix component. This may result in an erroneous reporting of sample 
concentrations. In the case of clinical trails, where dosing regimens are being optimized 
based on pharmacokinetic profiles and are dependant on accurate determination of drug 
plasma concentrations such miscalculations can lead to errors in determining optimum 
dosing regimens and in extreme cases failure of a drug in clinical trials. 
The degree of enhancement or suppression of ionization of an analyte by a given matrix 
component can be dependant on the physicochemical properties of the analyte. For 
example, highly polar compounds generally appear to be affected to a greater degree than 
less polar molecules which may be due in part to their co-elution with other polar 
components causing matrix effects. 
In most cases, matrix components which might cause ionization enhancement or 
suppression are removed during the sample clean-up process. The simplest form of sample 
clean-up is protein precipitation (PPT), in which an organic solvent, commonly acetonitrile 
(ACN), is combined with the sample of interest enabling most of the protein to be removed 
from the sample. Two additional methods of sample clean-up that will be discussed in 
greater detail later in this Chapter are liquid-liquid extraction (LLE) and solid phase 
extraction (SPE). These methods are more labor intensive, but generally result in better 
removal of matrix components. Along with sample clean-up, sample dilution is another 
simple technique effective in minimizing matrix effects. 
The exact mechanisms by which matrix components cause ionization suppression (or 
enhancement) are not known. However, King et al. have postulated that matrix components 
interfere with the processes involved in the transfer of the charged analyte (ion) into the gas 
phase thereby increasing or decreasing the ionization efficiency (King et al., 2000).  
Preparation of standards in the same matrix as the sample and use of internal standards 
(ISTDs) which have similar or nearly identical chemical and chromatographic properties to 
the analyte help in further minimizing matrix effects. For this reason, a stable-isotope-
labeled analyte is typically the best choice for an internal standard and in many cases 
corrects for almost all matrix effects (Xu et al., 2007). 
In many cases, it may not be readily apparent that ionization suppression is occurring in a 
given LC-MS/MS method. Hence, methodologies have been developed to remedy this. A 
commonly employed technique for detecting ionization suppression involves comparing the 
LC-MS/MS chromatographic profiles of injections of blank extracted matrix to neat blank 
matrix (water) which are obtained while continuously infusing diluted analyte solutions 
post column (prior to entering the MS detector). 
Our understanding of matrix effects and how to handle them has continually progressed 
over the last decade. This Chapter will provide a short review of the current industry 
perspective on matrix effects.  
2. Detection of matrix effects 
There are several methodologies available to analytical scientists for detection and 
quantification of matrix effects. Selection of the particular methodology employed typically 
depends on the stage of the program (discovery or development). For example, compounds 
in early discovery generally receive a limited qualitative matrix effect evaluation, due to 
strict timelines for data generation, while compounds in development warrant more 
detailed quantitative evaluation.  
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2.1 Qualitative determination of matrix effects 
Post-column infusion of an analyte, as diagramed in Figure 1, is a fast and easy technique 
that can be used to qualitatively identify regions of ion suppression or enhancement in a 
particular matrix extract. In this technique, an extracted matrix sample is injected onto the 
HPLC column using the LC-MS/MS method for the analyte, while a steady flow of that 
analyte is infused into the effluent flow between the column and the mass spectrometer 
source. Additionally, a blank solution such as water, buffer, or the initial mobile phase 
mixture must also be injected to determine the baseline for the analysis. The regions of 
suppression or enhancement can be visualized in the resulting chromatograms by 
comparing the baseline obtained from the blank with each of the matrices tested (Figure 2). 
It is important to note that the degree of the effect will depend on the concentration of the 
analyte being infused. If the concentration of analyte being infused is too high, matrix effects 
could be masked. Any regions of enhancement or suppression must be compared with the 
retention time of the analyte. Investigation of matrix effects using this methodology with an 
internal standard is also highly recommended. 
 
 
 
 
Fig. 1. Post-column infusion schematic. 
2.2 Quantitative determination of matrix effects 
Post-extraction analyte spiking provides a more quantitative measure of matrix effects. One 
technique involves extracting two sets of samples; one set contains the analyte added to an 
extracted matrix (post-extraction sample), and the other contains the analyte in mobile 
phase, solvent, or buffer (external solution). Both sets of samples are prepared with 
equivalent concentrations of the analyte and then are processed identically. One can 
quantitate the degree of enhancement or suppression caused by the matrix effect(s) by use of 
the equations shown below (Matuszewski et al., 2003): 
 Matrix effect (%) = B / A * 100 (can also be calculated using (B-A/A) * 100) 
 Recovery (%) = C / B * 100 
 Extraction Efficiency (%) = C / A * 100 
A = external solution peak area, B = post-extraction sample peak area, C = extracted matrix 
peak area 
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Fig. 2. Infusion test: the red trace is the baseline chromatogram for a solution of 50% 
acetonitrile in water (reagent blank), the green trace is the extracted matrix blank, and the 
purple trace is an analyte sample in reagent blank. In this example, the region of 
suppression does not coincide with the analyte peak. Therefore, this LC-MS/MS method 
could be used for the analysis of this single analyte, but if metabolite analysis was needed, 
this method could prove to be inadequate. These experiments would need to be repeated as 
metabolite standards became available. 
 
 
*Positive value indicates percent enhancement, negative value indicates percent suppression 
Table 1. Example of matrix effect evaluation.  
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Table 2. Recovery for an analyte, at various concentrations, and internal standard (ISTD). 
The “extracted matrix” samples were spiked with analyte or ISTD prior to extraction, and 
the “post-extraction” samples were spiked with analyte or ISTD after extraction. The 
recovery of the analyte does not appear to be affected by concentration. 
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Matrix effect, as previously stated, is a measure of percent change in signal caused by matrix 
components. Table 1 shows results from an experiment designed to determine matrix 
effects. The calculated matrix effect (%) shows that the analyte and the internal standard 
responses in this experiment are not affected by matrix effects. Extraction efficiency is a 
measure of the percent of total response in an extracted sample when compared to the 
external solution. Sample recovery describes the percent of analyte that was recovered 
during the extraction process. Table 2 shows an evaluation of recovery for an analyte and 
internal standard for three concentrations.  
The most rigorous technique for determining matrix effects is typically not performed until 
a compound advances into regulated animal studies where a Good Laboratory Practice 
(GLP) method validation is required. It involves analysis of three sets of samples for each 
matrix being evaluated. Each set is prepared as a series of calibration standards with 
internal standard; one set is prepared in mobile phase, solvent, or buffer (external solution), 
the second is prepared by addition of analyte to extracted matrix (post-extraction sample), 
and the third is prepared by addition of analyte directly into the study matrix (Matuszewski 
et al., 2003). 
3. Mechanisms of matrix effects 
3.1 Mechanisms of matrix effects 
Matrix effects arise at the interface between the LC system and the MS system (King et al., 
2000). This interface is referred to as the ‘ion source’, and it is here that analytes are 
desolvated and charged. The principals of MS detection dictate that only charged (positive 
or negative) gas phase ions are detectable. Anything that interferes with either the charging 
or the desolvation of the analyte will produce a matrix effect.  
 
 
 
 
Fig. 3. Applicability of various ion sources depending on analyte polarity and molecular 
weight. 
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A complete overview of MS interface design is beyond the scope of the present work; 
however, some understanding of the different operating principles of the major ion sources 
is useful for examining the root causes of matrix effects. In modern LC-MS there are a 
variety ion sources available from which the analyst can choose. This choice often depends 
on a number of factors including source availability, type of analyte, and sensitivity of the 
instrument. Figure 3 shows the three most commonly used ion sources, and their 
applicability for use based on analyte polarity and molecular weight. Electrospray 
ionization (ESI) is the most widely used ion source. It has broad applicability to a wide 
spectrum of analytes of varying molecular weight and polarity, and it is capable of ionizing 
larger macromolecules such as peptides and proteins. Atmospheric pressure chemical 
ionization (APCI) is the next most widely used ionization method. Additionally, there are a 
number of alternative source designs such as atmospheric pressure photo ionization (APPI), 
nano-spray (low volume ESI), and inductively coupled plasma mass spectrometry (ICPMS). 
Regardless of the type of source, all share a single goal of transitioning uncharged analytes 
in solution to detectable gas phase ions. 
3.2 Electrospray Ionization 
In the ESI source, analytes must acquire a charge in solution and then successfully transition 
to gas phase while maintaining their charge. Figure 4 depicts a generic ESI source. The 
acquisition of charge in the solution phase and successful transitioning to the gas phase 
makes the ESI source the most vulnerable to matrix effects when compared to either APCI 
or APPI (Jessome and Volmer, 2006; King et al., 2000; Trufelli et al., 2011). 
 
 
Fig. 4. ESI source. 
www.intechopen.com
 
Tandem Mass Spectrometry – Applications and Principles 
 
396 
The mobile phase containing the analyte along with appropriate mobile phase additives 
such as formic acid or ammonium hydroxide are passed through a charged needle, which 
transfers this charge to the exterior surface of the solution. At the tip of this charged needle, 
the solution takes the form of a narrow cone of charged liquid called a Taylor cone. Through 
the use of nebulising gasses and heat, the droplets are aerosolized. As these charged 
droplets transverse the ESI source they are progressively reduced in size through 
evaporation until they become completely desolvated gas-phase ions. These ions are then 
directed into the orifice of the mass spectrometer. Figure 5 depicts the desolvation of the 
charged droplets (containing the uncharged analyte) to the charged gas phase ions that are 
detected by the mass spectrometer. 
 
 
Fig. 5. ESI desolvation process. 
Within the ESI source, there are a number of factors which can affect the ability of the 
analyte to be consistently ionized. Figure 6 depicts some of the causes of matrix effects that 
may occur while the analyte is still in the liquid phase in an ESI source. Endogenous and 
exogenous co-eluting sample components can cause suboptimal droplet formation. 
Oversized droplets, or droplets with non-volatile components, are difficult to completely 
desolvate and can result in solution phase analyte collecting around the orifice or inside the 
quadrupole chamber, which can cause signal suppression (Bonfiglio et al., 1999; King et al., 
2000). Certain sample components such as the surfactants Tween 80 or PEG 400 have a high 
affinity for the air-liquid interface of a droplet. As the charge is also localized at the surface 
of the droplet, this affinity for the surface of the droplet can limit an analyte with less 
surface affinity from gaining access to the charge (Xu et al., 2005). In addition to surfactants, 
phospholipids can also interfere with an analyte’s access to the surface of the droplet, and 
thus hinder access to the charges located on the droplet’s surface (Bennett and Liang, 2004; 
Chambers et al., 2007). Ion-pairing reagents, typically used to improve chromatography, can 
interfere with an analyte’s ability to accept a charge. In ESI, the charge is localized on the 
surface of the droplet; therefore any co-eluting sample component can interfere with an 
analyte’s migration to the surface of the droplet. This interference occurs via competition 
with the analyte for the charge or repulsion of the analyte away from the surface thereby 
preventing ionization of the analyte. In charge competition scenarios, the charge will go to 
analyte or matrix component with the greatest ionization potential at the pH of the mobile 
phase. 
Non-volatile materials, such as phosphate (a common HPLC mobile phase buffer that is 
generally avoided for LC-MS/MS work), can accumulate inside the MS source housing, on 
the orifice of the detector, or on the front face of the mass spectrometer’s quadrupoles. 
Samples may also contain components (for example endogenous lipids) that can precipitate 
inside an ion source. The accumulation of non-volatile materials can increase electrical  
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Fig. 6. Mechanisms of ion suppression in LC-MS. 
resistance, thereby preventing the ions from following the electromagnetic gradient into the 
detector, resulting in signal loss (Mei, 2005). These deposits can also block the orifice, 
physically preventing entrance into the MS detector.  
 
 
Fig. 7. Accumulation of non-volatile components in ESI sources: A: shows a recently cleaned 
source with no accumulations; B: shows a crystalline ring of deposits resulting from polar 
matrix components and endogenous electrolytes; C: shows a slightly greasy smear around 
the orifice that may be the result of insufficient sample clean-up of endogenous lipids. 
In modern mass spectrometers, the LC inlet is orthogonal to the MS orifice. This 
configuration allows ions to follow the electrical charge gradient to the orifice and into the 
MS. Previous generations of LC-MS/MS instruments were designed with the LC inlet and 
the MS orifice aligned in a linear placement. This linear source design tended to have more 
issues with matrix effects and non-volatile accumulation in the source and the front of the 
MS quadrupoles, which often resulted in degradation of MS performance more rapidly. 
Figure 7 shows the orifices of several LC-MS/MS systems including clean and with build up 
of non-volatile components. 
Nano-scale ESI, a variant of conventional ESI sources that relies on ultra low amounts of 
solvent, has been reported to reduce matrix effects (Chiu et al., 2010). The reduced volumes 
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used in nano-scale ESI sources diminish the potential impact of matrix effects on the droplet 
formation and desolvation. 
3.3 Atmospheric pressure chemical ionization 
Atmospheric pressure chemical ionization (APCI) is an alternate method of analyte 
ionization to ESI. Although less susceptible to matrix effects, APCI can have significantly 
lower ionization efficiencies for some analytes. In such cases, the loss of analyte signal 
sensitivity must be weighed against the reduction of matrix effects (Trufelli et al., 2011). 
APCI, unlike ESI, does not rely on solution phase analyte charging, therefore many of the 
matrix effects due to droplet formation and phase transformation are eliminated. Instead, 
desolvation of the analyte occurs almost instantly in a heated ceramic vaporizing collar at 
the inlet from the LC. However, the high temperature required for desolvation makes APCI 
unsuitable for the quantitative analysis of thermally labile molecules. Figure 8 depicts a 
typical APCI ion source. 
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Fig. 8. APCI source. 
APCI is not immune to matrix effect issues of its own (Gosetti et al., 2010). In APCI, ion 
creation occurs as the desolvated neutral analyte and solvent molecules pass through the 
gas phase solvent ions (plasma) produced by the corona needle. The corona needle 
discharges electrons that initially charge the gas phase solvent molecules, and this charge is 
then transferred to the analyte. The ionization process must occur with a limited amount of 
transferrable charge in a very short amount of time. Thus, co-eluting species passing 
simultaneously through the corona often compete with the analyte for available charge. In a 
positive ionization mode, any component with a higher pKa can affect analyte signal 
intensity (van Hout et al., 2003). For example, Tween 80, a common excipient in drug 
formulations, competes with the analyte for charge thereby lowering the ionization 
efficiency of the analyte (Xu et al., 2005). Co-precipitation of analyte with non-volatile matrix 
components can also play a role in APCI signal suppression (van Hout et al., 2003). 
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3.4 Atmospheric pressure photo ionization 
Atmospheric pressure photo ionization (APPI) is a recently introduced ionization source 
that achieves ionization by channeling the uncharged gas phase sample molecules through a 
charged photon beam. APPI has been demonstrated to be less susceptible to matrix effects 
than ESI and APCI. APPI, like APCI, ionizes the analyte in the gas phase, eliminating 
potential issues that arise from solvent phase ionization. Additionally, APPI produces 
higher energy protons that can overcome potential charge competition between the analyte 
and solvent or extraneous materials, which sometimes occurs in APCI sources (Gosetti et al., 
2010). Figure 9 shows an APPI source diagram. 
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Fig. 9. APPI interface. 
3.5 General Considerations 
In experiments with multiple analytes, it is necessary to evaluate potential matrix effects for 
each analyte. Many factors, including pKa, solvation energy, solvent properties, etc., affect 
electrospray ion formation. Furthermore, each of these factors can impact various analytes 
within a mixture differently (King et al., 2000).  
In general, the consensus is that APCI and APPI systems are less prone to suffer from matrix 
effects than ESI, however, each method has its advantages and disadvantages (King et al., 
2000). In certain matrices and for certain analytes, no significant improvement over ESI 
sources was observed, emphasizing that matrix effects should be assessed on a compound-
by-compound and matrix-by-matrix basis (Lien et al., 2009). 
Although it may be possible to resolve an observed matrix effect by changing sources, this is 
not always an option. For example, analytes often exhibit different ionization efficiencies 
depending on the mode of ionization. Moreover, changing ion sources does not guarantee 
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elimination of matrix effects. A better option is to understand the specific cause of the matrix 
effect and then address it directly.  
4. Sources of matrix effects 
Ionization suppression and/or enhancement due to sample matrices have become one of the 
most important causes for failures and errors in bioanalysis. Matrix effects are subdivided 
into two groups: 1) endogenous matrix effects caused by components naturally occurring in 
the biological or environmental sample and 2) exogenous matrix effects caused by 
components introduced prior to or during sample collection and analysis. 
Commonly encountered sources of matrix effects are summarized below: 
 Endogenous components of matrices such as lipids, phospholipids, proteins, and bile 
salts 
 Exogenous components of matrices that are introduced during analysis such as 
formulation excipients, leachables from the labware, anticoagulants, analyte stabilizers 
used during sample collection, and reagents used in the preparation of bioanalytical 
samples 
 Degradation products of the analyte created during sample preparation and analysis 
(e.g. degradation products of prodrugs and compounds sensitive to pH, temperature, 
or light) 
 Impurities and salts contained in analytes and ISTDs 
 Poor recovery of analytes due to binding to biological matrices or containers (e.g. non-
specific binding of hydrophobic analytes to plastic) 
 Solvents and additives used for LC 
 Xenobiotics and their metabolites present in analytical samples (e.g. other drugs present 
in patient samples) 
The sources of matrix effects are extremely diverse and are analyte-, LC-MS/MS method- 
and ion source-dependent. Therefore, great care should be taken during method 
development and validation to identify potential issues (Matuszewski, 2006; Taylor, 2005; 
Trufelli et al., 2011; Vogeser and Seger, 2010). 
During the bioanalytical method development and validation for GLP studies, many of the 
exogenous matrix effects are addressed by careful evaluation of the reagents and supplies 
used for sample collection, preparation, and analysis. However, some matrix effects are 
difficult to identify and prevent during early stage drug discovery when a large number of 
diverse compounds are evaluated in a high-throughput manner and general LC-MS/MS 
methods are used. The problem is exacerbated by matrix effects resulting from impurities 
present in investigational compounds, such as inorganic and organic salts, and degradation 
products. Some exogenous and endogenous matrix effects are well known and have been 
described in literature, but many remain undetermined and are rarely explored in detail. A 
limited number of extensive and systematic studies have been performed to assess the broad 
nature of matrix effects providing much needed information regarding mechanisms of 
matrix effects in general and methods for their elimination (Chambers et al., 2007; Ismaiel et 
al., 2010; Little et al., 2006; Mallet et al., 2004; Marchi et al., 2010; Muller et al., 2002; Tong et 
al., 2002; Xu et al., 2005). In contrast, most of the current knowledge is based on studies 
focused on specific matrix effects. In every day practice, ion suppression is often overcome 
using empirical methods such as modification of LC-MS/MS methods, substitution of 
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HPLC columns, more rigorous sample clean-up, and optimization of labware and reagents 
without identifying or fully exploring the underlying causes.  
4.1 Exogenous components leading to matrix effects 
4.1.1 Eluents and additives 
The composition of the mobile phase profoundly influences the ionization efficiency of all 
sample components due to the mechanisms discussed previously (Gao et al., 2005; 
Kostiainen and Kauppila, 2009). Multi-fold increases in signal of the analyte can be achieved 
by modifying composition of the mobile phase during the LC-MS/MS analysis. For 
example, an increase in the organic solvent portion of the mobile phase usually leads to 
increased ionization efficiency (Dams et al., 2002). Such modifications can also lead to 
changes in retention times of analytes and matrix components thereby altering elution 
patterns and potentially introducing matrix effects.  
Acidic, basic, ion-pairing or buffer salt additives in the mobile phase may have signal 
suppression or enhancement effects. Mallet and colleagues performed a systematic analysis 
of formic acid (FA), acetic acid (AA), trifluoroacetic acid (TFA), ammonium hydroxide, 
ammonium formate, ammonium biphosphate, ammonium bicarbonate, and 
nonafluoropentadecanoic acid as mobile phase additives and studied their effect on the MS 
signal intensity of a diverse set of compounds (Mallet et al., 2004). Ionization enhancement 
or suppression was highly dependent upon each additive, analyte and ionization mode. 
Consistent with numerous other reports, TFA strongly suppressed ionization of all tested 
compounds in both positive and negative ionization modes. The signal suppressing effects 
of TFA and other fluorinated acids are due to the ion-pairing and surface tension effect (as 
described previously), which disrupts the ionization of the analyte (Gustavsson et al., 2001). 
The post-column addition of a propionic acid and 2-propanol mixture may counteract the 
deleterious effects of TFA by facilitating TFA evaporation during ionization (Apffel et al., 
1995). Benijts and colleagues reported that addition of acids resulted in significant signal 
suppression in the analysis of environmental water samples for 35 endocrine disrupting 
chemicals in negative and positive ESI, while 1 mM ammonium formate reduced the matrix 
effect. Further improvements were achieved by sample clean-up and use of SIL-ISTDs 
(Benijts et al., 2004). 
Additionally, reagents used during sample collection and preparation that are retained in 
the analytical sample may lead to matrix effects. Mei et al. reported that commonly used 
anticoagulant Li-heparin enhanced ionization efficiency for some of the analytes (Mei et al., 
2003). Tris(hydroxymethyl)aminomethane (TRIS) buffer and nicotinamide adenine 
dinucleotide phosphate (NADPH) led to significant matrix effects during the analysis of 27 
highly diversified pharmaceutical compounds in microsomal samples when PPT was 
utilized for sample clean-up (Zheng et al., 2002). SPE based sample clean-up was shown to 
significantly reduce these matrix effects. Phosphate buffer and non-volatile ion-pairing 
reagents such as sodium dodecyl sulfate (SDS) lead to severe ion suppression due to 
accumulation in the source as discussed in Section 3.2. 
4.1.2 Leachables and impurities 
Matrix effects caused by polymers and plasticizers leaching from common labware are often 
overlooked (Guo et al., 2006; Mei et al., 2003; van Hout et al., 2003). Importantly, ion source 
contamination with these polymers may lead to long-lasting interference with analysis. 
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Particular care should be exercised when organic solvents such as ethyl acetate, 
dichloromethane, or ethers are used with polymer-based containers, caps, or solid phase 
materials, as they may solubilize polymers and plasticizers. Minor solvent impurities and 
additives may also affect the accuracy of analyses (Annesley, 2007). 
4.1.3 Formulation agents 
Some formulation agents may also lead to matrix effects. In particular, excipients used in 
early drug discovery for solution or suspension formulations are known to interfere with 
analyses. These excipients are present in plasma at high concentrations (>1 mg/mL) in early 
PK sampling time points. In studies conducted by Xu and colleagues, 20% hydroxypropyl-β-
cyclodextrin (HPβCD) or 0.4% methyl cellulose vehicles did not lead to matrix effects either 
during iv or po dosing. Conversely, when 0.1% Tween 80 was used as a vehicle, 50-80% ion 
suppression was observed for both iv and po administration routes (Xu et al., 2005). These 
results are supported by several other researchers (Larger et al., 2005; Shou and Naidong, 
2003; Tong et al., 2002). Moreover, polysorbates including Tween 80 are complex mixtures of 
components containing polyoxyethylene (POE) sorbitan and POE sorbitan monoesters 
(Figure 10). POE sorbitan contains approximately twenty ethylene oxide subunits arranged 
in four chains of various lengths. The oleate monoester accounts for 58–85% of esters in 
Tween 80, while the remaining esters have alkyl chains from C14 to C18 and include 
stearate, linoleate, and linoleneate esters. Therefore, the composition of Tween 80 is quite 
variable and depends on the manufacturing process (Hewitt et al., 2011). Additionally, 
Tween 80 is rapidly hydrolyzed to oleic acid and polyethoxylated sorbitan by esterases in 
rodent plasma leading to further variability in analyses (Larger et al., 2005; van Tellingen et 
al., 1999). Dosing vehicles containing PEG 400 also lead to ionization suppression, in 
particular, for early eluting compounds (Shou and Naidong, 2003; Tong et al., 2002; Weaver 
and Riley, 2006; Xu et al., 2005). Co–infusion of PEG 400, Tween 80, or HPCD with an 
analyte in 70% ACN solution (pH 8) led to significant LC-MS signal suppression in positive 
and negative ionization modes, while co-infusion with propylene glycol (PG) resulted in the 
lowest interference among of the four (Tong et al., 2002). 
 
 
Fig. 10. Commonly used formulation agents. 
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4.1.4 Cross–talk 
Cross-talk occurs with compounds that produce fragments with similar masses. Typically, 
MRM dwell times and inter scan times are very short. Hence, fragment ions from one 
transition can still be present in the collision cell when the next MRM transition is 
monitored, leading to false positive signal. Most commonly cross-talk is observed when 
structural analogs or SIL-ISTDs are used as internal standards, or when metabolites of the 
analyte are present in the sample. On rare occasions, structurally unrelated compounds may 
produce ion fragments with an identical mass leading to cross-talk. Separate analysis of 
analytes and ISTDs while monitoring all MRM ion transitions is the most reliable method 
for cross-talk detection. Similar evaluation should be done with known metabolites or 
analyte degradation products when feasible. The simplest way to eliminate cross talk is to 
enter a “dummy” or blank MRM transition between mass transitions where cross-talk is 
observed. The dummy or blank transitions allow the collision cell to completely clear the 
ions from the previous mass transition. Additionally, cross-talk can be eliminated by 
reducing the amount of ions entering the collision cell. Therefore, dilution of the analyzed 
sample, reduced concentrations of ISTDs, or chromatographic resolution of the analyte and 
the ISTD is typically used to eliminate cross-talk (Morin et al., 2011).   
4.1.5 Stable-isotope-labeled internal standards 
Stable-isotope-labeled internal standards (SIL-ISTDs) are routinely used in pharmacokinetic 
analyses and in clinical and forensic toxicology to mitigate matrix effects during LC-MS/MS 
analysis (Stokvis et al., 2005). SIL-ISTDs are compounds where several atoms of the analyte 
molecule have been replaced with their stable isotopes. Most commonly hydrogen (1H) is 
exchanged for deuterium (2H) and carbon (12C) is exchanged for carbon (13C), however, 
nitrogen (15N) and oxygen (17O) labeled SIL-ISTDs also can be used. At least three atoms 
should be exchanged during the labeling to avoid interference between analyte and SIL-
ISTD signals due to cross-talk or signal contribution caused by isotope distribution. 
Furthermore, SIL-ISTDs should be of high isotopic purity and stable during the analysis. For 
example, hydrogen-deuterium exchange has been observed in aqueous solutions, therefore 
13C labeling is preferred (Chavez-Eng et al., 2002).  
SIL-ISTDs possess nearly identical physicochemical properties compared to their non-
labeled counterparts. Therefore, one may expect nearly identical retention times during 
chromatographic seperation and similar behavior in the ion source. Consequently, SIL-ISTD 
and an analyte should be exposed to the same ionization conditions and normalization 
relative to SIL-ISTD should minimize variability during the sample analysis. However, on 
occasion SIL-ISTDs themselves may lead to ion suppression or enhancement of the analyte 
(Liang et al., 2003; Remane et al., 2010b). To minimize SIL-ISTDs matrix effects, appropriate 
concentrations of SIL-ISTDs should be employed and linearity of the response should be 
tested. In addition, there have been reports that SIL-ISTDs are affected differently by matrix 
effects than the analyte leading to inaccurate quantification (Lindegardh et al., 2008; Jemal et 
al., 2003; Wang et al., 2007). 
4.1.6 In-source fragmentations  
Compounds with weak bonds, such as glucuronide- and sulfate-conjugated metabolites, 
may fragment in the source during the ionization process, thereby regenerating the parent 
molecule (Figure 11). When the analyte and its metabolite(s) are not resolved via 
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chromatography, in-source fragmentations may lead to inaccurate quantification of the 
analyte (Vogeser and Seger, 2010; Vogeser et al., 2001; Yan et al., 2003). 
 
 
 
 
 
Fig. 11. In-source fragmentation of a glucuronide metabolite resulting in interference of the 
parent analyte peak. 
4.2 Matrix effects caused by endogenous components 
Endogenous matrix effects are caused by components which naturally occur in the matrices 
(Table 3). Plasma and urine are the most commonly used biological samples for LC-MS/MS 
analysis, however, feces, saliva, bile, and tissue homogenates are occasionally analyzed as 
well. Each of these biological matrices contains distinct endogenous components that may 
lead to different matrix effects and require specific protocols for sample preparation. 
Furthermore, substantial variations in matrix effects can be observed in samples from 
different individual subjects due to genetic variation, disease state and/or the presence of 
other xenobiotic compounds (Remane et al., 2010a). Detection of endogenous substances, 
compounds with limited stability in biological matrices, and trace analytes are particularly 
prone to matrix effects.  
In general, polar compounds are affected more by endogenous matrix effects than non-polar 
compounds, because many components of biological matrices and environmental samples 
are polar, water-soluble compounds and are eluted early during a reverse phase (RP) 
chromatography (Bonfiglio et al., 1999; Muller et al., 2002). 
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Matrix Components Amount 
Blood  Plasma ~55% 
Red blood cells ~45% 
White blood cells  >1% 
Plasma  Water ~90% 
Protein  ~8% 
Inorganic salts 0.9% 
Organic substances (lipids, hormones, vitamins etc.)  1.1% 
Urine Water 95% 
Urea 9.3 g/L 
Chloride 1.87 g/L 
Sodium 1.17 g/L 
Potassium 0.75 g/L 
Creatine  0.67 g/L 
Other ions and compounds  lesser amounts  
Liver bile* 
 
Water  90-95% 
Total solids  5-10% 
Bile salts (bile acids)  3-45 mM 
Bilirubin 1-2 mM 
Phospholipids 150-800 mg/dL 
Free Cholesterol 80-200 mg/dL 
Protein (total) 2-20 mg/dL 
Glutathione 0-5 mM 
Sodium 140-170 mM 
Potassium 2.7-6.7 mM 
Calcium 2.5-6.4 mM 
HCO3- 12-55 mM 
*Data adopted from (Dancygier, 2010) 
Table 3. General composition of biological matrices. 
4.2.1 Plasma 
Plasma contains dissolved proteins, amino acids, peptides, glucose, carbohydrates, vitamins, 
electrolytes, hormones and lipids, all of which may lead to matrix effects. Serum protein is a 
major component of plasma with concentrations ranging from 6.0 to 8.3 g/dL. Albumins, 
globulins, and fibrinogens constitute approximately 60%, 18% and 4% of the total serum 
plasma protein, respectively. Albumin serves as a transport protein for carrying large 
organic anions, such as fatty acids, bilirubin, drugs, and hormones, such as cortisol and 
thyroxine. Albumin concentrations may vary among individual subjects and are affected by 
dehydration, protein malnutrition, kidney and liver disease, etc. Non-specific binding of 
analytes to albumin and globulins or specific binding to particular plasma proteins may 
impact analyte recovery during the analytical sample preparation. High affinity, specific 
binding may be of particular concern during analysis of naturally occurring compounds, 
their analogues, and highly potent drugs. For example, analysis of vitamins D2, D3, and 
their metabolites requires disruption of protein binding and longer chromatography 
methods to avoid matrix effects (Casetta et al., 2010; Hollis, 2007; Vogeser and Seger, 2010). 
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In most cases, analyte binding to proteins can be disrupted by organic solvent, acid, 
inorganic salt, or metal ion treatment. In MS/MS analysis acids, salts, or metal ions may 
lead to undesired ion suppression on their own and therefore are rarely used. Organic 
solvent based PPT efficiently removes most of the protein and does not require post-
precipitation processing of samples. In a study conducted by Polson et al., a volume ratio of 
2.5:1 of precipitant to plasma was found to maximize protein removal while minimizing 
sample dilution. Under these conditions, ACN precipitation removed >97% of protein, 
while methanol removed ~94% of protein (Polson et al., 2003). LLE and SPE also rely on use 
of organic solvents to efficiently disrupt analyte-protein interactions and remove proteins 
from the samples; therefore, proteins rarely lead to matrix effects in LC-MS/MS analysis of 
small molecules. However, endogenous amino acids and peptides can interfere with 
protein, peptide and peptidomimetic analysis. Albumins and immunoglobulins along with 
other abundant plasma proteins lead to significant ion suppression in proteomics and 
interfere with the detection of less abundant proteins (Ahmed et al., 2003; Lo et al., 2009). 
Recently, significant efforts have been devoted to the development of LC-MS/MS-based 
biomarker assays for diagnostic purposes (Ahmed et al., 2003; Apweiler et al., 2009; Pusch et 
al., 2003). Affinity chromatography and sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-page) can be utilized to deplete plasma samples of highly abundant 
proteins and improve detection limits of biomarkers (Ahmed et al., 2003; Borg et al., 2011; 
Liu et al., 2009). 
Other plasma matrix components such as salts, sugars, amino acids, lipids, and vitamins are 
not removed as efficiently by PPT, while LLE or SPE are better suited for this purpose as 
will be discussed in section 5.1. The highly polar components of plasma such as electrolytes, 
amino acids, glucose, and vitamins rarely interfere with analysis of non-polar organic 
compounds typically encountered in the drug development process, as they are easily 
separated by HPLC. However, they may lead to matrix effects when very rapid LC methods 
are used. 
Lipids are considered the main culprit of matrix effects in blood and plasma samples. 
Plasma contains thousands of distinct lipids comprised of six main categories including fatty 
acyls, glycerolipids, glycerophospholipids, sphingolipids, sterols, and prenols (Figure 12) 
(Quehenberger et al., 2010). Phospholipids are present in plasma at extremely high 
concentrations, with glycerophosphocholines and lysophospholipids constituting up to 70% 
and 10% of the total plasma phospholipids, respectively. Phospholipids have a polar head 
group that contains an ionizable negatively charged phosphate group and a positively 
charged amine group that are responsible for strong ion suppression in both positive and 
negative ionization modes (Chambers et al., 2007). In addition, phospholipids contain one or 
two fatty acid esters that are responsible for the hydrophobicity of phospholipids. In 
general, ACN extracts contain significantly lower amounts of residual lipids than methanol 
or acetone extracts (Chambers et al., 2007; Ismaiel et al., 2010). LLE can provide cleaner 
samples, but lipid separation depends heavily on pH and organic solvents used for the 
extraction (Chambers et al., 2007; Ismaiel et al., 2010; Muller et al., 2002). Non-polar lipids 
such as triacylglycerols, cholesterol, and cholesterol esters have good solubility in hexane, 
chloroform, and ethers and will be extracted with these solvents from plasma. On the other 
hand, polar lipids, such as phospholipids, are more soluble in polar solvents, such as 
methanol and ethyl acetate. Therefore, it is important to determine which lipids lead to 
matrix effects and select solvents for LLE or SPE that will not extract these lipids. Since 
phospholipids are more likely to lead to pronounced matrix effects, the use of less polar 
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solvents, such as methyl tert-butyl ether (MTBE) and MTBE-hexane mixtures for LLE can 
help to minimize matrix effects caused by phospholipids (Bennett and Liang, 2004; Ismaiel 
et al., 2010). Similar considerations apply to SPE sample clean-up, but derivatized 
solid-phase columns can provide efficient phospholipid removal (Aurand and Trinh, 2009; 
Chambers et al., 2007). 
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Fig. 12. Representative structures of endogenous lipid classes in human plasma (Fahy et al., 
2005). 
Chromatographic resolution of non-polar analytes from phospholipids is complicated by 
several aspects. Among them, elution of phospholipids from RP columns requires long run 
times and high organic solvent concentrations (60-90%) which may lead to co-elution with 
many non-polar drug-like compounds. Moreover, plasma contains numerous phospholipids 
that elute at various retention times collectively leading to broad ion suppression regions. 
Finally, lipid and phospholipid concentrations and composition in plasma can vary greatly 
between individuals leading to high variability in the observed matrix effects. When rapid 
gradients and short LC methods are used, phospholipids are retained on the column leading 
to accumulation and subsequent degradation of the column, as well as sporadic elution of 
lipids. Ultimately, a more thorough sample preparation/clean-up method may be required 
to remove these lipids. 
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4.2.2 Urine 
In comparison to plasma, urine has much lower protein content and fewer matrix 
components. It primarily contains highly polar urea, inorganic salts, creatinine, and low 
quantities of carbohydrates, hormones, proteins, and metabolites of endogenous 
compounds (e.g. steroid metabolites, 2-oxoglutarate, succinate, citrate, dimethylglycine, 
trimethylaminoxide and taurine) and xenobiotics (e.g. xenobiotic glucuronides). Therefore, 
matrix effects are observed less frequently and simple sample dilution is sufficient to resolve 
observed matrix effects (Bell et al., 2011; Schreiber et al., 2007; Schreiber and Formal, 2007). 
However, it is important to note that, the composition and pH of urine is considerably more 
variable compared to plasma and is affected by age, gender, disease state, and dietary 
habits. Thus, pH adjustment of samples may be needed and calibration samples may not be 
representative of the matrix from individual samples. 
5. Overcoming matrix effects 
Strategies for overcoming issues associated with matrix effects will be reviewed in this 
section. Figure 13 and Table 4 summarize the various method modifications that can be 
applied to eliminate matrix effects. 
 
 
 
 
 
 
Fig. 13. Addressing matrix effects. 
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Source of Matrix Effect Example Impact Potential 
solutions 
References 
Endogenous Lipids Lyso- 
Phosphotidylcholine 
18:0 
Suppression; 
late elution (if 
not fully 
eluted it can 
impact 
subsequent 
runs) 
Adjust 
gradient 
King et al., 
2000 
Polar matrix 
components 
K+, Ca++ Suppression, 
especially 
early in the
run 
HILIC column Hsieh, 
2008; Ji et 
al. 2008 
Exogenous Formulation 
components 
Tween 80, PEG 400 Suppression, 
especially for 
early eluters 
Increase 
mobile phase 
pH 
Weaver & 
Riley, 2006 
Labware Plasticizers Suppression, 
later in run, if 
not fully 
eluted it can 
impact 
subsequent 
runs 
Lengthen LC 
run; change 
labware 
supplier 
Guo, 2006; 
Mei, 2003; 
van Hout, 
2003 
In-source 
fragmentation
Glucuronide- and 
sulfate-conjugate 
metabolites 
Enhancement 
if it co-elutes 
with parent 
Modify source 
parameters 
(temperature 
or voltage); 
Additionally, 
changes can 
be made to 
the LC 
gradient or 
column 
temperature 
Vogeser, 
2001; 
Vogeser, 
2010; Yan, 
2003 
Table 4. Examples of matrix effects, their impact, and suggested solutions. 
5.1 Sample preparation 
Protein precipitation (PPT) is a rapid, nonspecific method that can be utilized for sample 
clean-up in a high-throughput, automated manner. PPT-based purification relies on reduced 
solubility of proteins and highly polar matrix components in aqueous-organic solvent 
solutions. Acetonitrile, methanol or acetonitrile-methanol mixtures are most commonly used 
for PPT. More than 90% of plasma proteins can be removed from samples using PPT when 
the plasma to organic solvent ratio is at least 1 to 2.5 (Chambers et al., 2007; Polson et al., 
2003). Unfortunately, many matrix components such as lipids, formulation agents, and other 
substances remain in the supernatant following centrifugation. These components often 
cause ion suppression, leading to increased variability between samples. Alternative sample 
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preparation and extraction techniques include SPE and LLE. However, these extraction 
methods are much more labor intensive and therefore they are not typically used in early 
drug discovery. A comprehensive discussion of LLE and SPE is beyond the scope of this 
manuscript, and only a brief description of each will follow. 
Liquid-liquid extraction (LLE) is based on the partitioning of an analyte into two separate 
liquids. The technique works by taking advantage of the differential solubility of an 
analyte in two immiscible liquids. One of the phases usually is water or a buffer solution, 
while the other is an organic solvent such as toluene, diethyl ether, hexane, 
dichloromethane, or MTBE. Selection of the proper organic solvent to obtain maximum 
recovery should be based on the analyte’s solubility in the particular solvent. Chambers et 
al. compared LLE methods to several SPE and PPT methods in terms of each technique’s 
overall cleanliness, matrix effects, and analyte recovery. They found that using MTBE and 
basified MTBE with a single extraction technique resulted in clean extracts that were 
similar to those obtained from cation exchange SPE and were better than PPT. However, 
analyte recovery using these two LLE methods significantly decreased compared to cation 
exchange SPE with basified methanol - average % recovery values for MTBE LLE, basified 
MTBE LLE, and cation exchange SPE with basified methanol were 43%, 38%, and 94%, 
respectively. Yet, when they used basified MTBE with a two step extraction procedure, 
both the cleanliness and analyte recovery (average of 87%) increased (Chambers et al., 
2007). While LLE provides clean extracts and decent analyte recovery, it is much more 
labor intensive than PPT. Furthermore, as evidenced by the Chambers’ investigation, 
multiple extractions may be necessary to obtain a sufficient quantity of analyte, 
decreasing overall efficiency that is essential for high-throughput sample clean-up and 
analysis in early drug discovery. 
Solid phase extraction (SPE) methods rely on the affinity of an analyte for a stationary phase 
and are often used to isolate analyte(s) of interest from a wide range of matrices including 
urine, blood, tissue homogenates, etc. Depending on the properties of the analyte and the 
solid phase, either the analyte of interest is retained while the unwanted matrix components 
elute with the solvent wash. Or the unwanted matrix components are retained and the 
analyte elutes with the solvent wash. In the first case, the retained analyte is subsequently 
eluted with a different solvent. There are numerous SPE stationary phases available, 
including normal phase, reversed phase, and ion exchange (Chambers et al., 2007; Supelco, 
1998). In addition, more specialized solid supports such as HILIC, mixed-mode resins, and 
zirconium coated particles for phospholipid removal are also commercially available. Table 
5 shows typical analyte, matrix, and stationary phase/sorbent examples. The stationary 
phase and eluent can be adjusted to achieve the optimal sample clean-up and analyte 
recovery. For example, extraction of primary, secondary, and tertiary amines from biological 
fluids would be best accomplished by using strong cation exchange (SCX stationary phase); 
whereas extraction of large, hydrophobic molecules from biological matrices or water 
should be performed via reversed phase SPE with a C18-T (wide pore) stationary phase 
(Phenomenex, 2009). Optimal SPE conditions depend upon physicochemical properties of 
analytes and matrix components in the samples and require extensive method development. 
Therefore, SPE is less useful for a high-throughput analysis of a diverse set of compounds 
encountered in the early stages of the drug discovery but is widely used for clinical sample 
analysis. A more thorough discussion on LLE and SPE can be found elsewhere (Wilson et 
al., 2000). 
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SPE Phase Analyte Properties Eluting Solvent Properties Stationary Phase / Sorbent 
Normal 
Phase 
Moderate to highly 
polar  
Mid- to non-polar organic 
solvent (hexane, toluene, 
chloroform) 
Polar (CN, NH2, EPH, Silica, 
Alumina-N) 
Reversed 
Phase 
Low to moderately 
polar, hydrophobic
Non-polar or polar organic 
solvents with or without 
water, buffer, and/or strong 
acid or base 
Non-polar (C18, C8, SDB-L, 
Phenyl, CN) 
Ion 
Exchange 
Ionized/charge 
compounds  
Aqueous & low ionic 
strength buffers (biological 
fluids plus buffers) 
Polar (cation exchange: 
WCX, SCX, Screen-C; anion 
exchange: WAX/NH2, SAX, 
Screen-A) 
 
 
Table 5. Analyte, matrix, and stationary phase properties associated with three commonly 
used SPE methods (Phenomenex, 2009; Supelco, 1998). 
Relatively quick and simple approaches to overcome ion suppression are available and 
include reducing the volume of the sample injected and/or diluting the samples prior to 
injection. Sample dilution and reducing the injection volume simply decreases the amount 
of interfering matrix components introduced into the ion source (Choi et al., 2001; Taylor, 
2005). Schuhmacher et al. has demonstrated that dilution of samples with mobile phase 
results in reduced ion suppression. In their study, dilution from 10- to 100-fold allowed 
investigators to identify that the matrix effects were caused by the vehicles (PEG 400 and 
Solutol) used for dosing (Schuhmacher et al., 2003). 
Some commonly encountered matrix effects are caused by formulation agents. The easiest 
approach for reducing these matrix effects is to avoid formulation agents that are known to 
lead to significant ionization suppression (e.g. Tween 80, PEG 400, Solutol). Alternatively, 
modifying chromatographic conditions and/or implementing SPE can be used to overcome 
formulation agent-caused matrix effects. One rather unique approach for eliminating 
vehicle-related matrix effects was reported by Schuhmacher et al. in which drugs for iv 
studies were formulated in the respective species’ plasma (Schuhmacher et al., 2003). 
Column overload is caused by accumulation of matrix components which are not 
adequately removed during sample clean-up and is a common occurrence when a column 
has been used extensively and these components are not sufficiently eluted by the HPLC 
method. While reducing the injection volume may fix the issue for a short period of time, a 
better long term solution is to add a highly (95-100%) organic wash step after analyte 
elution. In extreme cases where washing does not resolve the problem, the LC column may 
need to be replaced. Figure 14 shows chromatograms before and after column replacement. 
The top two chromatograms show peak tailing caused by column overload. After the LC 
column was replaced, the bottom two chromatograms showed much sharper analyte and 
ISTD peaks. Additionally, column replacement increased the analyte signal for both the 
compound of interest and the ISTD. 
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Fig. 14. Chromatograms illustrating an example of column matrix overload, and the 
subsequent column replacement to overcome matrix effects. 
5.2 Chromatographic conditions 
Another widely used strategy for the reduction of matrix effects is the optimization of 
chromatographic conditions. In most cases, ion-suppression is caused by the co-elution of 
the matrix components with the analyte of interest. Therefore, with increased 
chromatographic separation between the analyte(s) and the matrix components, fewer 
matrix effects are likely to be encountered. 
Optimizing a gradient method involves modification of chromatographic parameters, such 
as initial and final eluent strength and gradient duration, all of which may prove 
advantageous for chromatographic resolution of matrix components away from the analyte 
(Schellinger and Carr, 2006). When Gallart-Ayala et al. developed the analytical method for 
determining bisphenols in soft drinks using LC-ESI-MS/MS, they observed that the 
responses of the analytes were 80-95% lower in the matrix than those obtained from a 
standard solution at the same concentration level. They then monitored the samples through 
both LC-UV and LC-MS/MS, and found that signal suppression was likely caused by the 
co-elution of the matrix components with the analytes. To reduce the ionization 
suppression, several strategies were successfully applied: 1) extension of the linear gradient 
duration from 1 min to 3 min; 2) lowering of the initial mobile phase organic content from 
50% to 15% methanol; 3) adjustment of the final mobile phase composition from 100% to 
80% methanol. The chromatographic peaks of the analytes were almost completely resolved 
from the matrix components and the matrix effects were greatly reduced (Gallart-Ayala et 
Compound chromatogram before column 
change. 
ISTD chromatogram before column change. 
Compound chromatogram after column 
change. 
ISTD chromatogram after column change. 
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al., 2011). A shorter gradient duration normally leads to greater matrix effects due to the 
reduction of chromatographic resolution between analytes and matrix components 
(Chambers et al., 2007). When matrix effects are caused by co-elution of matrix components 
and the analyte of interest, changing to another column type or manufacturer, increasing the 
column length and/or extending the gradient duration will typically resolve the issue. 
Alternatively, fine tuning the mobile phase solvent strength can prove to be effective to 
achieve chromatographic separation. Ye et al. used a mixture of methanol and ACN as the 
organic mobile phase, to minimize phospholipid-related matrix effects and maintain high 
sample throughput (Ye et al., 2011). 
Recently, an ultra-fast gradient approach also referred to as a “ballistic” gradient, allowed 
for analysis cycle times of 2 minutes or less (Romanyshyn and Tiller, 2001; Romanyshyn et 
al., 2000). Tiller and Romanyshyn studied matrix effects encountered using ultra-fast 
gradients and fast isocratic methods. They demonstrated that while both methods are 
subject to similar matrix effects, gradient elution had several advantages in reducing matrix 
effects. Gradient elution gave better separation of the analyte from the poorly retained polar 
components, and a more complete elution of highly retained contaminants from the column, 
thereby reducing the potential matrix effects during sample analysis. Moreover, the early 
and late chromatographic regions can be diverted to waste, thus reducing matrix 
components that can foul the MS source (Tiller and Romanyshyn, 2002). 
Ultra Performance Liquid Chromatography (UPLC) provides advantages over traditional 
HPLC in speed, sensitivity, and resolution of analytes (Novakova et al., 2006; Wren and 
Tchelitcheff, 2006). When analyzing nine different drugs in three surface water samples, Van 
De Steene and Lambert observed severe matrix effects using HPLC. After implementing 
analogue ISTDs, significant matrix effects were still observed. However, through UPLC 
implementation, these matrix effects were significantly reduced, and accurate quantitation 
of all nine compounds using analogue ISTDs became feasible (Van De Steene and Lambert, 
2008). With improved sensitivity and resolution, UPLC generally encounters fewer matrix 
effects and affords a more robust analytical method than HPLC. 
Mobile phase pH can influence the retention times of ionizable analytes (basic or acidic) by 
changing the ionization equilibrium. Under HPLC conditions with an acidified mobile 
phase, basic compounds are present as charged species. As a result, they are poorly retained 
on the column and elute early with a highly aqueous mobile phase (Chambers et al., 2007). 
Under acidic conditions, basic compounds may encounter matrix effects from salts and 
highly polar, poorly retained matrix components. Conversely, at basic pH, basic compounds 
stay neutral, are better retained, elute with high organic content mobile phase, and generate 
stronger MS signals. In a study of matrix effects caused by PEG 400, the basic analyte co-
eluted directly with PEG 400 under acidic mobile phase conditions. To overcome this, the 
mobile phase pH was increased to 10.5, and improved separation between the analyte and 
PEG 400 was achieved. This resulted in greatly reduced matrix effects and allowed for more 
accurate quantification of the analyte (Weaver and Riley, 2006). 
Analytical columns of the same stationary phase (for example C18) from different 
manufacturers are generally not equivalent and will often result in slightly different 
separation of sample components. Hence, the degree of a matrix effect may differ when 
columns from different manufacturers are used. For example, in developing a ballistic 
gradient, De Nardi & Bonelli compared matrix effects after using an ACE C18-300 30x2.1mm 
(5µ) and a POLARITY dC18 30x2.1mm (5µ) analytical column. The analyte peaks had no 
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overlap with the PEG 400 peaks when using the ACE column, while partial overlap 
occurred when using the POLARITY column (De Nardi and Bonelli, 2006).  
A relatively new column, the hydrophilic interaction LC (HILIC) column, consists of bare 
silica or a polar phase (amino, diol, cyano, etc.) bonded to silica and provides more 
favorable conditions for polar compound retention and ionization (Hsieh, 2008) (Ji et al., 
2008). With HILIC chromatography, polar analytes have prolonged retention times and 
elute at high organic mobile phase content; therefore, they are separated from ion 
suppressing-early eluters and have high ionization efficiencies. Ji et al. developed a 
quantitation method for doxazosin using HILIC-MS/MS with a mobile phase consisting of 
ACN/ammonium formate (100 mM, pH 4.5) (93:7 v/v). The method was free of matrix 
effects assessed by post extraction analyte spiking (Ji et al., 2008). However, it is important to 
note that under HILIC conditions, certain polar endogenous components could be strongly 
retained on a HILIC column, potentially causing matrix effects that are not observed in RP 
conditions (Jian et al., 2010). Although water is usually used as the strong solvent in HILIC, 
by switching from water to a weaker solvent (methanol, ethanol, propanol etc.), HILIC 
columns can be used to effectively separate less polar compounds (Jian et al., 2010; Xu et al., 
2007). 
As discussed earlier, cleaner samples are obtained from SPE or multiple LLE. However, 
with the ever-increasing pace in drug discovery study, minimal sample pretreatment and 
automation are desired. Consequently, on-line 2-D chromatography with valve switching 
technology has seen more and more use lately (Mullett, 2007; Pascoe et al., 2001; Pol and 
Hyotylainen, 2008). Two-dimensional chromatography involves the transfer of a fraction or 
fractions of sample from a primary column to a secondary column for further separation. In 
orthogonal 2-D chromatography two columns with different stationary phases are utilized 
to increase the separation between the analyte and the matrix components. Dodgen et al. 
developed a simple method for simultaneous quantitation of dextromethorphan, 
omeprazole, and their metabolites in plasma for the phenotypic profiling of cytochrome 
P450 2D6 and 2C19. In this study, the supernatant generated from PPT was loaded directly 
to a SPE capture column for purification. After the initial unretained matrix components 
eluted, a switching valve directed the trapped analytes to the analytical column. The 
primary SPE column removed almost all ion suppression/enhancement effects caused by 
the matrix components. The total run time was 6 min (Dodgen et al., 2011). 
5.3 Calibration with internal standards 
Perhaps the most common method used to compensate for matrix effects involves the 
appropriate choice of ISTDs. When performing PPT, the ISTD is typically included with the 
organic solvent that is used to precipitate the protein. It is added to the precipitating solvent 
so that there is a uniform concentration throughout the samples to be analyzed. For an ISTD 
to effectively compensate for matrix effects it should have a retention time similar to the 
analyte of interest. The analyte response can be normalized to the ISTD peak simply by 
dividing the analyte peak area by the ISTD peak area. Since the ISTD concentration is equal 
across all of the samples, comparing the analyte’s peak area to the ISTD’s peak area serves to 
normalize the data and compensate for signal response variability caused by matrix effects. 
Ideally, a stable-isotope-labeled analyte analog can be used as an ISTD. Since this SIL-ISTD 
would have nearly identical chemical and structural properties as the analyte of interest, the 
two compounds should behave similarly during sample preparation and LC-MS analysis 
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(Jessome and Volmer, 2006). However, availability and cost concerns can severely limit the 
extent to which SIL-ISTDs are employed (Schuhmacher et al., 2003; Xu et al., 2007). 
6. Regulatory perspectives 
A complete discussion regarding the regulatory perspective on matrix effects is beyond the 
scope of this review and has been discussed in detail elsewhere (Viswanathan et al., 2007). 
In short, analysis of samples from GLP and clinical studies require a validated LC-MS/MS 
method. The Food and Drug Administration (FDA) has provided a guidance document for 
validating methods for the analysis of bioanalytical samples (FDA, 2001). This guidance 
provides details on the parameters required for a complete validation including method 
linearity, precision, accuracy, sample stability, evaluation of matrix effects, etc. The FDA 
recently required incurred sample analysis in which a subset of samples (~10%) from 
clinical and GLP studies are reanalyzed. The reanalysis results are compared to the original 
results, and that at least two-thirds of the reanalysis batch results must be within 20% of the 
original sample values. Failure to meet this criterion will initiate an investigation to 
determine the source of the discrepancy in the data. 
Although the parameters described above almost always lead to a robust, validated method, 
there are certain situations where matrix effects may persist. In such cases, sample 
reanalysis generally leads to widely different results from what was originally reported. 
These cases are frequently associated with unknown matrix effects, which are often unique 
to a particular patient’s sample(s). As mentioned previously, clinical trial samples are 
distinctive in their composition, thus a universal LC-MS/MS method will not always 
remove or compensate for the components that may interfere with analyte quantitation. 
Further, method validation across different patients’ samples is impractical due to this 
inherent uniqueness. These situations, when they occur, are handled on a case by case basis. 
Typically, an investigation into the discrepancy is conducted and documented and the 
reporting of the data is specified by Standard Operating Procedures (SOPs) that are written 
to handle such situations.  
7. Conclusion 
Matrix effects can be a complicated and time consuming challenge for the analytical chemist 
charged with developing robust, reproducible, and accurate analytical methods. There are a 
diversity of sample and system conditions that lead to matrix effects, and an equally diverse 
set of potential options to remedy them.  
The mechanisms by which matrix components cause ionization suppression (or 
enhancement) are still not well-understood. This serves as a testament to the challenge they 
provide to the analytical chemist. In the years since the first published articles describing 
matrix effects, analytical chemists have recognized the importance of understanding and 
mitigating matrix effects.  
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